today announced the presentation of a poster at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025 in Chicago. The presentation describes the ...

today announced the presentation of a poster at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025 in Chicago. The presentation describes the company’s ...

--(BUSINESS WIRE)--ClearB Therapeutics ... announced today that an abstract will be presented as a poster at the European Association for the Study of the Liver (EASL) International Liver Congress ...

The poster presentations will include preclinical ... of the Company’s product candidates and platform; potential business development and partnering transactions; potential market opportunities ...

Allarity (ALLR) Therapeutics announced the presentation of a poster containing data on a new DRP, Drug Response Predictor, for the monoclonal antibody drug daratumumab. The poster is to be ...

ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that an abstract will be presented as a poster at the ...

The Undergraduate Research Symposium was held on Thursday at the Illini Union displaying research by students from all disciplines.

Walnut Hill Medical, a leader in patient access solutions for innovative medical therapies, is proud to announce that Dr. Michael C. Burgess has agreed to provide consultative services as a Strategic ...

However, five years on from Covid, “Slob chic” remains the norm, and the “Saturday morning walk to the paper shop” aesthetic is still acceptable for work calls. Many companies have relaxed their dress ...

They said the interdisciplinary nature of the delegation made the presentation more difficult ... the variety of attendee backgrounds at the poster session made it hard to use that type of ...

Highlights include work focused on AI, precision medicine, immunotherapies and more LOS ANGELES--(BUSINESS WIRE)--Researchers ...

Alto Neuroscience, Inc. ("Alto") a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced multiple ...